Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Opiant Pharmaceuticals Stock Quote

Opiant Pharmaceuticals (NASDAQ: OPNT)

Opiant Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
OPNT -28.79% -2.18% -0.44% -83%
S&P +20.62% +72.50% +11.51% +352%

Opiant Pharmaceuticals Company Info

Opiant Pharmaceuticals is a pharmaceutical company that develops treatments for drug overdose and addictions leveraging intranasal and injectable delivery technologies. The company, formerly known as Lightlake Therapeutics, was founded in 2009, has a team of addiction experts, and is headquartered in Santa Monica, California.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.